VIVS
VivoSim Labs, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.16
+0.38%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.25
- EPS estimate
- —
- Revenue actual
- $18.0K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +4.7%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | — | -$0.25 | — | $18.0K |
| Feb 18, 2026 | -$2.40 | -$2.28 | Beat 5.00% | $26.0K |
| Nov 6, 2025 | -$2.28 | -$0.98 | Beat 57.02% | $28.0K |
| Aug 12, 2025 | — | -$1.14 | — | $37.0K |
| May 30, 2025 | -$2.28 | -$3.48 | Miss -52.63% | $51.0K |
| Feb 19, 2025 | -$0.21 | -$0.19 | Beat 9.52% | $24.0K |
| Nov 8, 2024 | -$0.26 | -$0.14 | Beat 46.15% | $30.0K |
| Jun 30, 2024 | — | -$2.74 | — | $39.0K |
| Mar 31, 2024 | — | -$3.07 | — | $29.0K |
| Dec 31, 2023 | — | -$4.74 | — | $5.0K |
| Sep 30, 2023 | — | -$5.50 | — | — |
| Jun 30, 2023 | — | -$5.54 | — | $75.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026